HEYER DEVARAPALLI: Open Payments
NPI 1588704381 · ARLINGTON HEIGHTS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,244 in 99 payments from 25 companies in 2025. Trend: 2023 $3,705 · 2024 $6,344 · 2025 $4,244
Food & beverage: $4,244
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $686 |
| Smith+Nephew, Inc. | 7 | $454 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $390 |
| Lilly USA, LLC | 8 | $333 |
| MIMEDX Group, Inc. | 3 | $294 |
| Novo Nordisk Inc | 9 | $287 |
| AstraZeneca Pharmaceuticals LP | 7 | $232 |
| Edwards Lifesciences Corporation | 2 | $209 |
| Corcept Therapeutics | 4 | $167 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $158 |
Products named: JARDIANCE, GRAFIX PL, REPATHA, EVENITY, SAPIEN 3 Ultra RESILIA, Ozempic, Korlym, Kerendia.
Industry payments across IL — which companies pay providers there.
